摘要
目的研究纤溶酶治疗急性脑梗死疗效和对脑血流的影响。方法将60例急性脑梗死患者随机分为纤溶酶组和对照组,在常规治疗基础上纤溶酶组30例给予纤溶酶治疗,对照组30例给予香丹注射液治疗。治疗前、后1月均对纤溶酶组和对照组进行神经功能缺损评分及疗效评定、经颅三维多普勒(TCD)脑血流检查。结果纤溶酶组和对照组有效率分别为60.00%和33.33%(P<0.01),纤溶酶组较对照组脑血流明显改善(P<0.05)。结论纤溶酶有效改善脑梗死临床症状,促进脑血流恢复。
Objective To study the clinical curative effects of fibrinolysin on acute cerebral infarction and cerebral blood flow.Methods Sixty cases were randomly divided into fibrinolysin groups and control groups,30 cases were each per group.fibrinolysin group of cases were given conventional therapy in fibrinolytic,control groups of cases were given with Xiangdan injection,Scores of neurological dysfunction and efficacy evaluation were performed in both fibrinolysin group and control group before and after 1-month treatment.transcranial three dimensional doppler sonography check cerebral blood flow.Results After one month therapy the effective rate was 60.00%in fibrinolysin groups and 33.33%in control groups(P0.01),Cerebral blood flow were improved in fibrinolysin groups(P0.05).Conclusion fibrinolysin may obviously improve clinical symptoms and promote cerebral blood flow in patients with acute cerebral infarction.
出处
《当代医学》
2011年第33期128-129,共2页
Contemporary Medicine
关键词
纤溶酶
脑梗死
药物疗法
Fibrinolysin
Cerebral infarction
Drug therapy
